CVE-2022-41945

Public Exploit
Remote Code Execution (RCE) vulnerability in super-xray via URL input

Description

super-xray is a vulnerability scanner (xray) GUI launcher. In version 0.1-beta, the URL is not filtered and directly spliced ​​into the command, resulting in a possible RCE vulnerability. Users should upgrade to super-xray 0.2-beta.

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.32%
Third-Party Advisory github.com Third-Party Advisory github.com
Affected: 4ra1n super-xray
Published at:
Updated at:

References

Link Tags
https://github.com/4ra1n/super-xray/security/advisories/GHSA-732j-763p-cvqg third party advisory exploit
https://github.com/4ra1n/super-xray/releases/tag/0.2-beta third party advisory release notes

Frequently Asked Questions

What is the severity of CVE-2022-41945?
CVE-2022-41945 has been scored as a medium severity vulnerability.
How to fix CVE-2022-41945?
To fix CVE-2022-41945, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-41945 being actively exploited in the wild?
It is possible that CVE-2022-41945 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-41945?
CVE-2022-41945 affects 4ra1n super-xray.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.